関連する実験動画

Updated: Jul 19, 2026

A Functional Whole Blood Assay to Measure Viability of Mycobacteria, using Reporter-Gene Tagged BCG or M.Tb (BCG lux/M.Tb lux)
08:10

A Functional Whole Blood Assay to Measure Viability of Mycobacteria, using Reporter-Gene Tagged BCG or M.Tb (BCG lux/M.Tb lux)

Published on: September 14, 2011

マンプスワクチンの評価

D J Nokes, R M Anderson

    Lancet (London, England)
    |April 25, 1992
    PubMed
    まとめ

    No abstract available in PubMed .

    さらに関連する動画

    Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
    09:03

    Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

    Published on: June 19, 2018

    Micro-Colony Forming Unit Assay for Efficacy Evaluation of Vaccines Against Tuberculosis
    06:26

    Micro-Colony Forming Unit Assay for Efficacy Evaluation of Vaccines Against Tuberculosis

    Published on: July 28, 2023

    関連する実験動画

    Last Updated: Jul 19, 2026

    A Functional Whole Blood Assay to Measure Viability of Mycobacteria, using Reporter-Gene Tagged BCG or M.Tb (BCG lux/M.Tb lux)
    08:10

    A Functional Whole Blood Assay to Measure Viability of Mycobacteria, using Reporter-Gene Tagged BCG or M.Tb (BCG lux/M.Tb lux)

    Published on: September 14, 2011

    Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
    09:03

    Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

    Published on: June 19, 2018

    Micro-Colony Forming Unit Assay for Efficacy Evaluation of Vaccines Against Tuberculosis
    06:26

    Micro-Colony Forming Unit Assay for Efficacy Evaluation of Vaccines Against Tuberculosis

    Published on: July 28, 2023

    関連する概念動画

    Vaccinations01:51

    Vaccinations

    Overview
    Vaccines01:21

    Vaccines

    Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
    Poliomyelitis01:17

    Poliomyelitis

    Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...

    共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

    Epidemiology of COVID-19 infections on routine polymerase chain reaction (PCR) and serology testing in Coastal Kenya.

    Wellcome open research·2022

    Quantifying previous SARS-CoV-2 infection through mixture modelling of antibody levels.

    Nature communications·2021

    The importance of supplementary immunisation activities to prevent measles outbreaks during the COVID-19 pandemic in Kenya.

    BMC medicine·2021

    Molecular characterization of rotavirus group A strains circulating prior to vaccine introduction in rural coastal Kenya, 2002-2013.

    Wellcome open research·2019

    Human rhinovirus spatial-temporal epidemiology in rural coastal Kenya, 2015-2016, observed through outpatient surveillance.

    Wellcome open research·2019

    Evaluating the performance of tools used to call minority variants from whole genome short-read data.

    Wellcome open research·2018

    1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

    Lancet (London, England)·2026

    Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

    Lancet (London, England)·2026

    Advancing the relevance of clinical trials for older patients.

    Lancet (London, England)·2026

    Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

    Lancet (London, England)·2026

    Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

    Lancet (London, England)·2026

    Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

    Lancet (London, England)·2026

    The Role of the Mitochondrial Permeability Transition Pore in Chronic Pain.

    Current neuropharmacology·2026

    Protein Profile of Multiple Myeloma-Derived Extracellular Vesicles for the Discovery of Novel Myeloma-Related Biomarkers.

    Cancer science·2026

    Two-photon imaging microscopy of non-stained human epiretinal membranes.

    Biomedical optics express·2026

    Disseminated Culture-Negative Periprosthetic Knee Infection With Multifocal Septic Arthritis Associated With Mycoplasma pneumoniae: A Case Report.

    Case reports in orthopedics·2026

    Lung Infection Due to Species Infrequently Isolated in the Community Setting: Klebsiella variicola and Acinetobacter baumannii.

    Cureus·2026

    Associated Factors on Cytomegalovirus Reactivation in Patients with COVID-19 in the Intensive Care Unit.

    Mediterranean journal of hematology and infectious diseases·2026
    関連記事をすべて見る
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    JoVEについて
    概要リーダーシップブログJoVEヘルプセンター
    著者向け
    出版プロセス編集委員会範囲と方針査読よくある質問投稿
    図書館員向け
    推薦の声購読アクセスリソース図書館諮問委員会よくある質問
    研究
    JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
    教育
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
    利用規約
    プライバシーポリシー
    ポリシー
    Jove
    Visualize
    お問い合わせ